GC-05 Group. Maimonides Biomedical Rese... Publications | LitMetric

Clinical Trial Review Systematic Review Meta-Analysis Books and Documents Randomized Controlled Trial

1 results match your criteria: "GC-05 Group. Maimonides Biomedical Research Institute of Cordoba (IMIBIC).[Affiliation]"

Page 1 of 1

Safe Treatment With Secukinumab in a Patient With Axial Spondyloarthritis and a History of a Infection.

J Rheumatol

November 2023

GC-05 Group. Maimonides Biomedical Research Institute of Cordoba (IMIBIC).

Clementina López-Medina Antonio Doblas Alejandro Escudero-Contreras Eduardo Collantes-Estévez

View Article and Find Full Text PDF

Similar Publications